LENANAMO (Lenalidomide) affect how your immune system works. It is used in the treatment of multiple myeloma and myelodysplastic syndrome.
USES
- Multiple myeloma, myelodysplastic syndrome
- Mantle cell lymphoma
- Follicular lymphoma
GUARANTEE & EXPIRY DATE
100% original from Indian SHIVNAAM TRADELINK LLP. Product photo may vary.
All packs are air tight sealed and expire up to 11.2026.
DESCRIPTION
Lenanamo belongs to the group of therapy known as Immunomodulatory agents. It contains the active ingredient Lenalidomide. It is indicated to treat adults with multiple myeloma, mantle cell lymphoma, myelodysplastic syndrome and follicular lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. These cells gather in the bone marrow and split uncontrollably. This type of cancer cannot be cured; however, the symptoms can be alleviated. Myelodysplastic Syndrome is a group of various blood and bone marrow diseases where the blood cells become abnormal and do not function properly. Mantle cell lymphoma is a less common type of cancer that affects the lymph nodes. Follicular lymphoma is a slow-growing cancer that affects the B cells.
Lenanamo activates T cells and natural killer cells of the immune system and facilitates the attack on cancer cells. It works by antagonizing the growth of blood vessels in the cancer cells and delaying the development of cancer cells. It inhibits the growth and multiplication of tumor cells.
PACKAGING & DOSAGE
Strength: 10mg or 25mg
Packaging type: Bottle.
Packaging size: 30 tablets.
Composition: Lenalidomide (10mg or 25mg)
Standard Dosage Guidelines:
Multiple Myeloma (MM): Initial Dose: 25 mg once daily on days 1–21 of a 28-day cycle.
Myelodysplastic Syndromes (MDS) with 5q Deletion: Dose: 10 mg once daily continuously. Treatment continues until disease progression or unacceptable toxicity.
Mantle Cell Lymphoma (MCL): Dose: 25 mg once daily on days 1–21 of a 28-day cycle.
Follicular and Marginal Zone Lymphoma: Dose: 20 mg once daily on days 1–21 of a 28-day cycle, often combined with rituximab.
SIDE EFFECTS
Common side effects of Lenanamo include weakness, diarrhea, nausea, vomiting, taste change, and decreased appetite. The doctor may advise for regular monitoring of blood pressure and thyroid gland function while taking this medicine. It may decrease blood sugar levels. In fact, the levels can decrease to the extent that the patient may faint. So, if you are diabetic then it is important to check your blood sugar levels regularly. Additionally, you should also consult the doctor if the dose of anti-diabetic medicines needs to be adjusted.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or bleeding disorder. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
STORAGE
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
QUESTIONS?
Ask us any questions about Lenanamo.
